FLG Partners is proud to have assisted in raising over $6 Billion in growth financing, IPO, and M&A transactions since January 2021:

2023

Soleno Therapeutics Raises $129 Million Following Positive Clinical Results

Jim Mackaness
June 26, 2023

Kering Beauté aquires Creed

Monica Stevenson
June 26, 2023

Presidio Medical Announces $72M Equity Fundraising Led by Deerfield

Mark Murray
April 25, 2023

Human API Acquired by LexisNexis Risk Solutions

April 13, 2023

Saluda Medical Announces $150M Equity Financing

Laureen DeBuono
January 25, 2023

LogicMark, Inc. Announces Closing of $5.2 Million Underwritten Public Offering Priced Above Market

Mark Archer

2022

December 19, 2022

Soleno Therapeutics Announces Up to $60M Financing

Jim Mackaness
November 16, 2022

Curevo Announces $26M Series A-1 Financing

Greg Curhan
September 22, 2022

Rivus Pharma Closes $132M Series B

Eric Hall
September 9, 2022

Mission Bio Completes $40M Debt Financing

Patrick Nugent
September 6, 2022

Arsenal Bio Completes $220M Series B for Gene-edited Cell Therapies

Kenton Chow
August 10, 2022

Rani Therapeutics Completes Debt Financing up to $45M

Laureen DeBuono, Lead Independent Board Member, Audit Chair
August 8, 2022

Curevo Vaccine Secures $27.5M Growth Capital Term Loan

Greg Curhan
August 1, 2022

Apexigen Inc. Completes Business Combination to go Public

Linda Rubinstein
June 30, 2022

Novartis Acquires Kedalion Therapeutics

Mark Murray
June 22, 2022

Antheia Announces $40M in Venture Debt Financing to Construct New Plant

Patrick Nugent
April 7, 2022

DigiLens Completes Second Close of Its Series D $50M Funding

Eric Mersch
April 1, 2022

Soleno Therapeutics Raises $15M in Underwritten Public Offering

Jim Mackaness
February 10, 2022

Curevo Vaccine Announces $60 Million Series A

Greg Curhan
January 26, 2022

Kyverna Therapeutics Closes $85 Million Series B Financing

Jonathan Wolter
January 20, 2022

ONI Microscopy Platform Closes $75 Million Series B Financing

Anne Samak de la Cerda
January 19, 2022

Jumio Completes 4stop Acquisition

Kenton Chow

2021

November 15, 2021

Kedalion Therapeutics Secures Series B Funding and Announces Option to Acquire

Mark Murray
November 10, 2021

Level Home, Inc. Acquires Dwelo, Inc., Raises $100 Million + C Round

Bill Beyer
November 4, 2021

DigiLens Raises $55 Million in Series D Funding Led by Samsung

Eric Mersch
October 13, 2021

Lark Health Raises $100 Million Series D Funding

Bill Beyer
October 7, 2021

Zum Raises $130 Million Series D to Modernize School Transportation

Chris Cook
September 16, 2021

Elevian Raises $40 Million Series A to Advance Treatments for Stroke Recovery and Age-Related Diseases

Greg Curhan
September 15, 2021

Nxt-ID, Inc. Announces Pricing of $12.5 Million Underwritten Public Offering

Mark Archer
August 26, 2021

SmartRent Goes Public in $2.2 Billion SPAC Merger with $150 Million PIPE

Jonathan Wolter
August 25, 2021

RenovoRx IPO Raises $17 Million

Linda Rubinstein
August 25, 2021

Trove Secures $77.5 Million Series D Funding Round

Ron Fior
August 13, 2021

Rani Therapeutics IPO Raises $84.3 Million

Laureen DeBuono, Lead Independent Board Director, Audit Chair
August 5, 2021

Oyster Point Pharma Reports Q2 2021 Results Including $125 Million Credit Facility and License Agreement up to $205 Million

Mark Murray, Board Director
June 24, 2021

Elevation Oncology IPO Raises $115 Million

Eric Hall
June 10, 2021

Aktana Closes on $22.5m Senior Venture Debt Line with Innovatus Capital Partners and Armentum

Cal Hoagland
May 13, 2021

Vera Therapeutics IPO Raises $47.9 Million

Jonathan Wolter
April 1, 2021

Compass, Inc. IPO Raises $450 Million

Jennifer Cho
Jeff Kuhn
March 23, 2021

Jumio Raises $150 Million in Private Equity

Kenton Chow
March 18, 2021

Connect Biopharma IPO Raises $220 Million

Eric Hall
February 5, 2021

Angion Biomedica Corp. IPO Raises $117 Million with Concurrent Private Placement

Greg Curhan
January 19, 2021

Vera Therapeutics Closes on $80 million Series C Equity Financing

Jonathan Wolter